Genomic risk scores in prostate cancer: polygenic yes, but are they poly-ancestral?

被引：0
|
作者：
Basu, Arnab [1 ,2 ]
Rais-Bahrami, Soroush [1 ,3 ,4 ]
机构：
[1] Univ Alabama Birmingham, Heersink Sch Med, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Heersink Sch Med, ONeal Comprehens Canc Ctr, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Heersink Sch Med, Dept Urol, Fac Off Tower 1120,510 20th St S, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Heersink Sch Med, Dept Radiol, Birmingham, AL 35294 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2024年 / 116卷 / 05期
关键词：
MEN;
D O I：
10.1093/jnci/djae025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：635 / 636
页数：2
相关论文
共 37 条
  • [21] Broad- and narrow-sense validity performance of three polygenic risk score methods for prostate cancer risk assessment
    Yu, Hongjie
    Shi, Zhuqing
    Lin, Xiaoling
    Bao, Quanwa
    Jia, Haifei
    Wei, Jun
    Helfand, Brian T.
    Zheng, Siqun. L.
    Duggan, David
    Lu, Daru
    Mo, Zengnan
    Xu, Jianfeng
    PROSTATE, 2020, 80 (01) : 83 - 87
  • [22] Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer
    Xu, Melody J.
    Kornberg, Zachary
    Gadzinski, Adam J.
    Diao, Dongmei
    Cowan, Janet E.
    Wu, Susan Y.
    Boreta, Lauren
    Spratt, Daniel E.
    Behr, Spencer C.
    Nguyen, Hao G.
    Cooperberg, Matthew R.
    Davicioni, Elai
    Roach, Mack
    Hope, Thomas A.
    Carroll, Peter R.
    Feng, Felix Y.
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (06): : 685 - 690
  • [23] Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review
    Chung, Jae-Seung
    Morgan, Todd M.
    Hong, Sung Kyu
    PROSTATE INTERNATIONAL, 2020, 8 (03) : 99 - 106
  • [24] Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial
    Carbunaru, Samuel
    Sun, Zequn
    McCall, Cordero
    Ofori, Bernice
    Marshall, Norma
    Wang, Heidy
    Abern, Michael
    Liu, Li
    Hollowell, Courtney M. P.
    Sharifi, Roohollah
    Vidal, Patricia
    Kajdacsy-Balla, Andre
    Sekosan, Marin
    Ferrer, Karen
    Wu, Shoujin
    Gallegos, Marlene
    Gann, Peter H.
    Moreira, Daniel
    Sharp, Lisa K.
    Ferrans, Carol E.
    Murphy, Adam B.
    CANCER MEDICINE, 2023, 12 (19): : 19690 - 19700
  • [25] Genomic Validation of 3-Tiered Clinical Subclassification of High-Risk Prostate Cancer
    Muralidhar, Vinayak
    Zhang, Jingbin
    Wang, Qiqi
    Mahal, Brandon A.
    Butler, Santino S.
    Spratt, Daniel E.
    Davicioni, Elai
    Sartor, Oliver
    Feng, Felix Y.
    Mouw, Kent W.
    Nguyen, Paul L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (03): : 621 - 627
  • [26] Development of prediction models based on risk scores for clinically significant prostate cancer on MRI/TRUS fusion biopsy
    Perez, Hector Ayerra
    Abad, Javier Fermin Barba
    Escudero, Julene Argaluza
    Cameno, Javier Extramiana
    Eizaguirre, Egoitz Tolosa
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (04) : 270.e9 - 270.e18
  • [27] Defining Prostate Cancer at Favorable Intermediate Risk: The Potential Utility of Magnetic Resonance Imaging and Genomic Tests
    Falagario, Ugo G.
    Beksac, Alp Tuna
    Martini, Alberto
    Cumarasamy, Shivaram
    Gupta, Akriti
    Prasad, Sonya
    Thulasidass, Hari
    Shah, Qainat N.
    Jayaratna, Isuru
    Lewis, Sara
    Rastinehad, Ardeshir R.
    Taouli, Bachir
    Cormio, Luigi
    Carrieri, Giuseppe
    Tewari, Ash K.
    JOURNAL OF UROLOGY, 2019, 202 (01) : 102 - 106
  • [28] Post-operative Radiation Therapy for Prostate Cancer Still no genomic Risk Profiling for clinical Routine
    Finazzi, Tobias
    Zimmermann, Frank
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (01) : 70 - 72
  • [29] Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer
    Belkacemi, Yazid
    Debbi, Kamel
    Coraggio, Gabriele
    Bendavid, Jerome
    Nourieh, Maya
    To, Nhu Hanh
    Cherif, Mohamed Aziz
    Saldana, Carolina
    Ingels, Alexandre
    de la Taille, Alexandre
    Loganadane, Gokoulakrichenane
    CANCERS, 2023, 15 (03)
  • [30] Intake of the Total, Classes, and Subclasses of (Poly)Phenols and Risk of Prostate Cancer: A Prospective Analysis of the EPIC Study
    Almanza-Aguilera, Enrique
    Guinon-Fort, Daniel
    Perez-Cornago, Aurora
    Martinez-Huelamo, Miriam
    Andres-Lacueva, Cristina
    Tjonneland, Anne
    Eriksen, Anne Kirstine
    Katzke, Verena
    Bajracharya, Rashmita
    Schulze, Matthias B.
    Masala, Giovanna
    Oliverio, Andreina
    Tumino, Rosario
    Manfredi, Luca
    Lasheras, Cristina
    Crous-Bou, Marta
    Sanchez, Maria-Jose
    Amiano, Pilar
    Colorado-Yohar, Sandra M.
    Guevara, Marcela
    Sonestedt, Emily
    Bjartell, Anders
    Thysell, Elin
    Weiderpass, Elisabete
    Aune, Dagfinn
    Aglago, Elom K.
    Travis, Ruth C.
    Zamora-Ros, Raul
    CANCERS, 2023, 15 (16)
1234